IL202002A0 - Method of treating diabetes - Google Patents

Method of treating diabetes

Info

Publication number
IL202002A0
IL202002A0 IL202002A IL20200209A IL202002A0 IL 202002 A0 IL202002 A0 IL 202002A0 IL 202002 A IL202002 A IL 202002A IL 20200209 A IL20200209 A IL 20200209A IL 202002 A0 IL202002 A0 IL 202002A0
Authority
IL
Israel
Prior art keywords
treating diabetes
diabetes
treating
Prior art date
Application number
IL202002A
Other languages
English (en)
Original Assignee
Gilead Palo Alto Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Palo Alto Inc filed Critical Gilead Palo Alto Inc
Publication of IL202002A0 publication Critical patent/IL202002A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL202002A 2007-05-31 2009-11-09 Method of treating diabetes IL202002A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/070140 WO2008147417A1 (en) 2007-05-31 2007-05-31 Method of treating diabetes

Publications (1)

Publication Number Publication Date
IL202002A0 true IL202002A0 (en) 2010-06-16

Family

ID=38812044

Family Applications (1)

Application Number Title Priority Date Filing Date
IL202002A IL202002A0 (en) 2007-05-31 2009-11-09 Method of treating diabetes

Country Status (11)

Country Link
EP (1) EP2152268A1 (ko)
JP (1) JP2010528112A (ko)
KR (1) KR20100038322A (ko)
CN (1) CN101678017A (ko)
AU (1) AU2007354300A1 (ko)
BR (1) BRPI0721741A2 (ko)
CA (1) CA2687381A1 (ko)
IL (1) IL202002A0 (ko)
MX (1) MX2009012957A (ko)
NO (1) NO20093592L (ko)
WO (1) WO2008147417A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011530A (es) 2002-05-21 2005-08-15 Cv Therapeutics Inc Administracion de un inhibidor de acido graso parcial tal como ranolazina para el tratamiento de diabetes.
US8822473B2 (en) 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
US20090111826A1 (en) * 2007-02-13 2009-04-30 Louis Lange Use of ranolazine for the treatment of cardiovascular diseases
RU2691620C1 (ru) * 2018-11-26 2019-06-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Способ прогнозирования риска развития ишемической болезни сердца у пациентов с сахарным диабетом 2 типа в сочетании с субклиническим тиреотоксикозом
CN110812344A (zh) * 2019-12-17 2020-02-21 卓和药业集团有限公司 一种治疗糖尿病合并心绞痛的药物组合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479496B1 (en) * 1998-09-10 2002-11-12 Cv Therapeutics, Inc. Methods for treating angina with ranolazine
MXPA04011530A (es) * 2002-05-21 2005-08-15 Cv Therapeutics Inc Administracion de un inhibidor de acido graso parcial tal como ranolazina para el tratamiento de diabetes.
BRPI0606403A2 (pt) * 2005-01-06 2009-06-23 Cv Therapeutics Inc formulações farmacêuticas com liberação sustentada e seus usos

Also Published As

Publication number Publication date
MX2009012957A (es) 2010-03-03
KR20100038322A (ko) 2010-04-14
NO20093592L (no) 2010-01-20
BRPI0721741A2 (pt) 2013-02-13
EP2152268A1 (en) 2010-02-17
AU2007354300A1 (en) 2008-12-04
JP2010528112A (ja) 2010-08-19
WO2008147417A1 (en) 2008-12-04
CN101678017A (zh) 2010-03-24
CA2687381A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
HRP20190408T1 (hr) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
IL212348A0 (en) Treatment method
EP2032131A4 (en) Methods of Treatment
PL2190883T3 (pl) Sposób obróbki biomasy
IL208354A0 (en) Methods of treatment
HK1148435A1 (en) Oxadiazoanthracene compounds for the treatment of diabetes
EP2174912A4 (en) PROCESS FOR MACHINING A COPPER ARSEN COMPOUND
GB0610746D0 (en) Method of treatment
EP2350641A4 (en) Methods of Treatment
IL200769A (en) A method for processing potash
PL2441462T3 (pl) Sposób leczenia cukrzycy typu I
EP2144886A4 (en) METHOD OF TREATING MELANOMA
IL202002A0 (en) Method of treating diabetes
GB0718684D0 (en) Treatment method
EP2164494A4 (en) Methods of Treatment
EP2498794A4 (en) METHOD FOR THE TREATMENT OF TYPE-2 DIABETES
ZA201007680B (en) Method of treating metalliferrous materials
EP2162021A4 (en) METHOD FOR TREATING FOODSTUFFS
EP2203432A4 (en) PROCESSING METHOD
GB0717337D0 (en) Method of treatment
ZA200907778B (en) Method of treating diabetes
GB0823435D0 (en) Method of treatment
GB0618227D0 (en) Novel method of treatment
ZA201102198B (en) Treatment method
GB0802903D0 (en) Treatment of diabetes